13 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

eMVFit (MVF-10M)

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

Oticon

FDA UDI
Sbo Hearing A/S·05714464057665·OTICON PLAY PX 2 MINIRITE T C044

BD MICROFINE+ INSULIN SYRINGES

FDA Adverse Event
Malfunction ·BD MEDICAL - DIABETES CARE·Product code FMF·April 26, 2019

AMBU DISPOSABLE PRESSURE MANOMETER

FDA 510(k)
FDA Class 2 ·Anesthesiology

RANFAC ASPIRATION NEEDLE WITH ADJUSTABLE GUIDE

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

SYRINGE 0.5ML 29GA 12.7MM BLISTER 200BX

FDA Adverse Event
Malfunction ·BD MEDICAL - DIABETES CARE·Product code FMF·April 5, 2019

ANIMAS INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·November 10, 2014

TERUMO CDI 500 BLOOD PARAMETER MONITOR

FDA Adverse Event
Malfunction ·TERUMO CARDIOVASCULAR SYSTEMS CORP.·Product code DRY·August 17, 2011

SPEEDLOCK IMPLANT WITH INSERTER HANDLE

FDA Adverse Event
Malfunction ·ARTHROCARE CORPORATION·Product code MBI·July 17, 2013

BD SYRINGE 0.5ML 29GA 12.7MM BLISTER 200BX

FDA Adverse Event
Malfunction ·BD MEDICAL - DIABETES CARE·Product code FMF·April 2, 2019

CLEO® 90 INFUSION SET

FDA Adverse Event
Injury ·SMITHS MEDICAL ASD, INC.·Product code FPA·May 16, 2017

CLEO® 90 INFUSION SET

FDA Adverse Event
Injury ·SMITHS MEDICAL ASD, INC.·Product code FPA·May 16, 2017

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014